Trial Outcomes & Findings for Dexamethasone and Lower Extremity Block Duration (NCT NCT01756586)

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

4 participants

Primary outcome timeframe

3 days

Results posted on

2017-06-27

Participant milestones
Measure	Control Plain bupivacaine Bupivacaine: Control	Experimental Bupivacaine with Dexamethasone Dexamethasone Bupivacaine: Control
Overall Study STARTED	2	2
Overall Study COMPLETED	0	0
Overall Study NOT COMPLETED	2	2

Withdrawal data not reported

Dexamethasone and Lower Extremity Block Duration

Baseline characteristics by cohort
Measure	Control n=2 Participants Plain bupivacaine Bupivacaine: Control	Experimental n=2 Participants Bupivacaine with Dexamethasone Dexamethasone Bupivacaine: Control	Total n=4 Participants Total of all reporting groups
Age, Categorical <=18 years	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	2 Participants n=5 Participants	2 Participants n=7 Participants	4 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Sex: Female, Male Female	1 Participants n=5 Participants	1 Participants n=7 Participants	2 Participants n=5 Participants
Sex: Female, Male Male	1 Participants n=5 Participants	1 Participants n=7 Participants	2 Participants n=5 Participants
Region of Enrollment United States	2 participants n=5 Participants	2 participants n=7 Participants	4 participants n=5 Participants

Timeframe: 3 days

Population: Did not have resources to follow up with the subjects after the surgery. The study was terminated early.

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

University of Chicago

Phone: 773-834 3643